Utah et al. v. Google LLC, No. 3:21-cv-05227 (N.D. Cal. July 7, 2021)

July 8, 2021

Thirty-seven states filed a lawsuit against Google for monopolizing the smartphone application market in violation of state and federal antitrust laws. According to the complaint, Google operates a web of exclusionary agreements with phone manufacturers and carriers to exert control over app distribution on Android phones through its Google Play Store. By leveraging those anticompetitive…

Read More →

NAAG Submits Comment Letter on Beneficial Ownership Regulations

May 6, 2021

Our comments are consistent with the sense of Congress, which requires that regulations “to the greatest extent practicable… collect information in a form and manner that is reasonably designed to generate a database that is highly useful to… law enforcement agencies…” NDAA § 6402(8)(C).

Read More →

California v. Denso, No. 2:19-cv-13566 (E.D. Mich. Dec. 3, 2019)

January 26, 2021

As part of its ongoing participation in the ongoing Automotive Parts multidistrict litigation, California reached a settlement with Denso to resolve claims that as part of a conspiracy with dozens of auto parts manufactures, competition in the automotive parts market was suppressed and eliminated by illegal bid rigging. The state’s complaint alleged that Denso had…

Read More →

Settlement Agreement Between Plaintiff States and UBS (Dec. 21, 2018)

January 8, 2021

Forty plaintiff states reached a $68 million settlement with UBS for fraudulent conduct involving interest rate manipulation that had a significant impact on consumers and financial markets around the world. UBS’ fraudulent conduct involved the manipulation of LIBOR (the London Interbank Offered Rate). LIBOR is a benchmark interest rate that affects financial instruments worth trillions…

Read More →

FTC et al. v. Vyera Pharmaceuticals, No. 1:20-cv-00706 (S.D.N.Y. Apr. 19, 2020)

January 4, 2021

The FTC, New York and six other states filed suit against Vyera Pharmaceuticals, its parent company, Phoenixus, and its former officers, Kevin Mulleady and Martin Shkreli in 2020, alleging anticompetitive conduct in connection with Daraprim, the only FDA approved drug for the treatment of the life-threatening parasitic disease toxoplasmosis.  The suit alleged that Vyera purchased…

Read More →

Attorneys General Urge Senate to Pass Law to Fight Shell Companies

October 26, 2020

As our States’ chief legal officers, we are concerned about the use of American financial institutions for money laundering by terrorist groups and other criminal enterprises.

Read More →

NAAG Endorses Stopping Overdoses of Fentanyl Analogues (SOFA) Act

October 22, 2020

States and localities are on the front line of this crisis and are a large part of winning the battle from both a law enforcement and public health perspective.

Read More →

California v. Quest Diagnostics Incorporated, No. CV-03-1358 MMM (C.D. Cal. 2003)

October 9, 2020

Merger of two clinical laboratories in California

Read More →

Smith Food & Drug Centers, Inc. Settlement Agreement

October 9, 2020

Smiths Food & Drug Centers, Inc. exited California market and sought antitrust review of proposed sales of supermarket sites to other supermarket operators. The sale of 18 stores to various supermarket operators were approved. Smiths? agreed to obtain prior approval or provide prior notice of future sales of sites to supermarket operators for a period of 5 years.

Read More →

People v. Omnimed Medical Services, et al

October 9, 2020

Supplier of radiology services offered to divide markets with radiologist who was bidding on contracts to supply radiology services to California prisons.

Read More →